Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TAVNEOS safely and effectively. See full prescribing information for TAVNEOS. TAVNEOS® (avacopan) capsules, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
TAVNEOS is indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids. TAVNEOS does not eliminate glucocorticoid use.
- generic_name
- avacopan
- product_names
- avacopan
- ndc
- 73556-168, 73556-168-01, 73556-168-02, 73556-168-96
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en